Substitution with doxorubicin for daunorubicin during induction for high risk pediatric acute lymphoblastic leukemia results in increased toxicity
Year: 2012
Type: article
Source: Pediatric Blood & Cancer
DOI: 10.1002/pbc.24325
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1998991618
